Praxis Precision Medicines (PRAX) Interest & Investment Income (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Interest & Investment Income of -$2.2 million for Q1 2026, down 43240.0% year-over-year from N/an in Q1 2025, and down 717.05% quarter-over-quarter from -$264000.0 in Q2 2025.
Praxis Precision Medicines (PRAX) Interest & Investment Income (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Interest & Investment Income history runs 8 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 43240.0% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$1.0 million (down 175.9% YoY), while the FY2022 annual figure was $957000.0, up 253.14% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$2.2 million, down from -$264000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.4 million in Q3 2024, with the low at -$2.2 million in Q1 2026.
- The 5-year median for Interest & Investment Income is $4000.0 (2024), against an average of $3750.0.
- The sharpest annual moves came in 2023 and 2026: Interest & Investment Income soared 135.81% in 2023, then slumped 43240.0% in 2026.
- Praxis Precision Medicines' Interest & Investment Income stood at $1.3 million in 2022, then plunged by 98.56% to $19000.0 in 2023, then surged by 7278.95% to $1.4 million in 2024, then tumbled by 118.83% to -$264000.0 in 2025, then tumbled by 717.05% to -$2.2 million in 2026.
- Business Quant data shows PRAX's Interest & Investment Income at -$2.2 million in Q1 2026, -$264000.0 in Q2 2025, and $5000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.32 Bn | 132.47 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.35 Bn | 58.16 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 63.15 Bn | 58.01 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.96 Bn | 36.86 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 28.14 Mn |
| 7 | Royalty Pharma | 27.67 Bn | 26.83 Bn | - | 5.13 Mn |
| 8 | BioNTech SE | 27.52 Bn | 9.13 Bn | 668.28 Mn | 115.94 Mn |
| 9 | Insmed | 26.98 Bn | 25.82 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Praxis Precision Medicines | 10.72 Bn | 9.96 Bn | - | -1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.08 Mn |
| Mar 31, 2026 | -2.16 Mn |
| Jun 30, 2025 | -264,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | -74,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Mar 31, 2023 | 154,000.00 |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 144,000.00 |
| Jun 30, 2022 | -74,000.00 |
| Mar 31, 2022 | -430,000.00 |
| Jun 30, 2021 | 36,000.00 |
| Mar 31, 2021 | -86,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 128,000.00 |
| Dec 31, 2019 | 22,000.00 |
| Sep 30, 2019 | 48,000.00 |